1
February 13, 2016
Scientific Program Outline
SECTION ON CARDIOLOGY & CARDIAC SURGERY
2014 AAP National Conference and Exhibition
DAY 1: Friday, October 10, 2014
San Diego, California
8:30 am
Abstract Presentations
9:30 am
BREAK
9:45 am
SYMPOSIUM 1: Optimization of Neurodevelopmental Outcomes:
Where We Are and What It Will Take
Session 1: State of the Art in Assessment of Neurodevelopmental
Outcomes: Current Recommendations and Rationale
Faculty: Bradley Marino, MD, FAAP
Session 2: Important Patient and Treatment-Related Factors in
Neurodevelopmental Outcomes
Faculty: Wiliam T. Mahle, MD, FAAP
Session 3: MRI and CNS Findings Related to Neonatal Cardiac
Surgery – Are There Underlying CNS Issues?
Faculty: Daniel Licht, MD
Session 4: Is Risk Stratification Possible: i.e., Can Optimization of
Patient Factors Have an Impact on Neurodevelopmental Outcomes?
Faculty: Gil Wernovsky, MD
Session 5: Genetic Factors and Neurodevelopmental Outcomes?
Faculty: Kathleen Mussatto, PhD, RN
Panel Discussion
12.45
LUNCH - Society for Pediatric Cardiology Training Program Directors
1:45 pm
Young Investigator Abstract Presentations
3.30 pm
BREAK
3:45 pm
Young Investigator Abstract Presentations
5:00 pm
Poster Question and Answer Session – Light refreshments served
6:00 pm
Adjourn
2
February 13, 2016
Scientific Program Outline
SECTION ON CARDIOLOGY & CARDIAC SURGERY
AAP National Conference and Exhibition
DAY 2: Saturday, October 11, 2014
San Diego, California
8:30 am
Abstract Presentations
10:15 am
BREAK
10:30 am
Abstract Presentations
12:00 pm
LUNCH: Pediatric Cardiology Fellows Workshop
1:00 pm
SYMPOSIUM 2: Towards a Genetic Understanding of Etiologies
and Prevention of Congenital Heart Disease
Session 1: The Genetic Basis of Congenital Heart Disease:
Simplicity and Complexity
Faculty: Bruce Gelb, MD
Session 2: Epigenetics and Congenital Heart Disease: What Is Its
Meaning and What Is Its Importance? A Primer for Pediatric
Cardiologists
Faculty: Aoy Tomita-Mitchell, MD
Session 3: Use of Genetic Testing in the Diagnosis and Risk
Stratification of Congenital Heart Disease: Review of Techniques,
Usefulness, etc. Should We Do It and Why Should We Do It?
Faculty: Jeffrey A. Towbin, MD, FAAP
Session 4: Future Genetic Interventions to Prevent Congenital
Defects Including Stem Cell Therapies
Faculty: Timothy Nelson, MD, PhD
Panel Discussion:
4:00 pm
Break
4:15 pm
Abstract Presentations
5:15 pm
Adjourn
7:00 pm
Section Banquet tickets required
3
February 13, 2016
Scientific Program Outline
SECTION ON CARDIOLOGY & CARDIAC SURGERY
AAP National Conference and Exhibition
DAY 3: Sunday, October 12, 2014
San Diego, California
8:30 am
Presentation of the 2014 Young Investigator Awards and Education
Travel Grants
W. Robert Morrow, MD, FAAP
8:35 am
Presentation of the 2014 Research Fellowship Award
Recipient:
Sponsored by the Helen and Will Webster Foundation
8:40 am
Presentation of the results of the 2013-2014 Research Fellowship Award
Presenter: David Kwiatkowski, MD
Sponsored by the Helen and Will Webster Foundation
9:00 am
Founders Award Presentation
9:05 am
Founders Address
9:35 am
BREAK
9:45 am
SYMPOSIUM 3: Long-Term Care of the Single Ventricle Patient:
Diagnosis, Prevention and Management of Long-Term Complications
Moderators: James Tweddell, MD, FAAP
Session 1: The Interventional Catheter Approach to the Single Ventricle
Patient: Opportunities to Improve Outcomes including a Discussion
about Coiling Collaterals, Creating Fenestrations and Other Potential
Interventions
Faculty: John W. M. Moore, MD, MPH, FAAP
Session 2: HLHS: Current Expectations, Risk Stratification, Are There
Higher Risk Subsets and What is the Correct Approach to those
Subsets?
Faculty: Steven Schwartz, MD
Session 3: HRHS/Pulmonary Atresia with Intact Ventricular Septum:
Are There Higher Risk Groups? How Do We Decide to Decompress the
RV? How Do We Decide to Go Down the Transplant Pathway? Is There
an Evidenced-Based Algorithm to Help Us Decide?
Faculty: Charles Fraser, Jr., MD, FAAP
11:15
BREAK
11:30
Session 4: Protein-Losing Enteropathy, Hepatic Dysfunction and Other
Complications/Co-Morbidities of the Fontan Physiology. Can They Be
Predicted? Can they be Prevented?
Faculty: Shaji Menon, MD, FAAP
4
February 13, 2016
Session 5: Is There a Role for Mechanical Support Either As a Bridge to
Transplant or as Destination Therapy in the Failed Single Ventricle
Patient. Evidence For and is it Even Possible?
Faculty: Ronald Woods, MD, FAAP
Session 6: The Role of Transplantation in the Single Ventricle Patient.
When, Why and Outcomes?
Faculty: Shelley Miyamoto, MD
Panel Discussion
1:30 pm
Adjourn